|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 14/605 | |
| C12N 1/15 | |||
| C12N 1/21 | |||
| C12N 5/10 | |||
| A61K 38/26 | |||
| A61K 38/00 |
| (11) | Number of the document | 2875043 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13756832.5 |
| Date of filing the European patent application | 2013-07-23 | |
| (97) | Date of publication of the European application | 2015-05-27 |
| (45) | Date of publication and mention of the grant of the patent | 2016-12-21 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2013/065519 |
| Date | 2013-07-23 |
| (87) | Number | WO 2014/016300 |
| Date | 2014-01-30 |
| (30) | Number | Date | Country code |
| 201261674706 P | 2012-07-23 | US | |
| 201361785611 P | 2013-03-14 | US | |
| 201300360 | 2013-06-14 | DK |
| (72) |
RIBER, Ditte, DK
GIEHM, Lise, DK
|
| (73) |
Zealand Pharma A/S,
Smedeland 36, 2600 Glostrup,
DK
|
| (54) | GLUCAGON ANALOGUES |
| GLUCAGON ANALOGUES |